Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Tumors
Interventions: DRUG: DS-8201a
Sponsor: UNICANCER
Collaborators: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company